DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo


company name or ticker

Spectrum Pharmaceuticals: A Long-Term Bet

Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval

Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog

Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 - Analyst Blog

H.C. Wainwright & Co. Sees Significant Upside Ahead For Spectrum Pharmaceuticals

Spectrum Pharmaceuticals: Key Drug Fusilev May Face Generic Competition Soon

Spectrum Pharmaceuticals Gains U.S. Approval of Beleodaq - Analyst Blog

A Bad Day for Spectrum Pharmaceuticals' Good News

Spectrum gets a drug approved, and then the share price drops.

Why Spectrum Pharmaceuticals (SPPI) Stock Is Higher This Morning

Monday’s Top Biotech Stories: Spectrum, Bristol-Myers Squibb, GSK, and Theravance

Spectrum, Bristol-Myers Squibb, GSK, and Theravance are the top biotech stocks to watch this morning.

This Week in Biotech: Allergan Three-Peats in a Bad Way While Agenus Impresses

An early FDA approval, an inhaled therapy being turned away by regulators for a third time, and three positive clinical updates are this week's top biotech stories.
See More Articles...